January 5, 2025 General Proximity Emerges from Stealth with $16M to Develop Induced Proximity Medicines for ‘Undruggable’ Targets Funding Biotechnology /
December 19, 2024 HERVolution Therapeutics Raises $11.7M Series A to Advance Dark Genome-Based Immunotherapies for Cancer and Aging Funding Biotechnology /
